Citrullinemia type I results from deficiency of the
Correct Answer: Argininosuccinate synthase
Description: (B) Argininosuccinate synthase# Citrullinemia type I (CTLN1) presents as a clinical spectrum that includes an acute neonatal form (the "classic" form), a milder late-onset form, a form without symptoms or hyperammonemia, and a form in which women have onset of severe symptoms during pregnancy or post partum.> Citrullinemia type I results from deficiency of the enzyme argininosuccinate synthase (ASS), the third step in the urea cycle in which citrulline is condensed with aspartate to form argininosuccinic acid.> Untreated individuals with the severe form of citrullinemia type I have hyperammonemia (plasma ammonia concentration 1000- 3000 pmol/L).> Plasma quantitative amino acid analysis shows absence of argininosuccinic acid and concentration of citrulline usually greater than 1000 pmol/L (normal: <50 pmol/L).> Argininosuccinate synthase enzyme activity, measured in fibroblasts, liver, and in all tissues in which ASS is expressed, is decreased.> ASS1 is the only gene in which mutation is known to cause citrullinemia type I.
Category:
Biochemistry
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now